Investing Profile

Josh Bilenker

VC
Photo of Josh Bilenker, Partner at Aisling Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
18
$280M
CompanyStageDateRound SizeTotal Raised
ViewRay
Post Ipo EquityJul 2015$27M
Series UnknownDec 2013$30M
Series UnknownMay 2013$15M
Series CMar 2012$45M
Debt FinancingSep 2011$10M
Series CAug 2010$20M
Series BJan 2008$25M
$170M
LENSAR
Private EquityJan 2015$16M
Series UnknownOct 2013$27M
Debt FinancingOct 2013$60M
Series UnknownMar 2012$24M
$130M
Loxo Oncology
Series BMay 2014$24M
Series AOct 2013$33M
$57M
Co-investors: David Bonita (OrbiMed), Dov Goldstein (Aisling Capital), James Barrett
T2 Biosystems
Series EMar 2013$40M
Series DAug 2011$23M
$96M
Co-investors: Harry Wilcox (Flagship Pioneering), Alan Crane (Polaris Partners), Michael Greeley (Flare Capital Partners), Stacy Feld (Johnson & Johnson Innovation)
Aragon Pharmaceuticals
Series DOct 2012$50M
Series BApr 2010$22M
$80M
Co-investors: Carl Gordon (OrbiMed), Brett Zbar (Foresite Capital), Peter Svennilson (The Column Group)
Roka Bioscience
Series DJan 2012$48M
$68M
Co-investors: Jonathan Silverstein (OrbiMed), James Barrett